Is FDA Less Confident In ANDAs? Stay On Efudex Generic May Set Precedent
Executive Summary
FDA's decision to review its approval of a generic for Valeant's topical Efudex (fluorouracil) Cream 5% may create a precedent for future approvals of ANDAs for complex small molecule drugs and could set the stage for higher hurdles for eventual approvals of biogenerics
You may also be interested in...
Generic Eloxatin Suspension Makes At Risk Launches A Little Riskier
Teva and Hospira halt shipments of oxaliplatin after an appeals court temporarily stays FDA approval of their ANDAs.
Generic Approval Standards For Vancomycin Tightened In FDA Draft Guidance
FDA has tightened approval standards for generic oral vancomycin, but appears to have left enough latitude in bioequivalence testing requirements to not greatly impede generic competition
Generic Approval Standards For Vancomycin Tightened In FDA Draft Guidance
FDA has tightened approval standards for generic oral vancomycin, but appears to have left enough latitude in bioequivalence testing requirements to not greatly impede generic competition